'Virtual biopsy' - A new way to look at cancer

May 29, 2003

COLUMBUS, Ohio - Scientists are using new imaging technology to help them perform "virtual biopsies," - biological profiles of specific tumors that may help predict a patient's response to treatment and probability of long-term survival. This whole new realm of imaging is called functional MRI (magnetic resonance imaging), a process that offers insight into a tumor's character, not just its superficial structure.

Using functional MRI, Dr. Michael Knopp, a radiologist and a member of The Ohio State University Comprehensive Cancer Center's Experimental Therapeutics Program, is studying breast, prostate, pancreatic tumors and others to see if some of their particular biological quirks are related to response to treatment and survival.

Knopp says while X-rays can reveal information about a tumor's size and shape, that information alone is not enough to help physicians plan and tailor some of the newest treatments. "It's not what we see, but what we don't that may be more important."

What X-rays don't show, but what functional MRI does, says Knopp, includes biological processes like angiogenesis, or blood vessel growth surrounding a tumor. Using MRI and special contrast agents, Knopp is able to determine the permeability, or "leakiness" of the tumor's support system. Early studies suggest the "leakier" the vessels, the more likely a patient will respond to treatment. "Functional MRI allows us to measure permeability; understanding that characteristic alone can help clinicians better manage the patient's care," says Knopp.

Functional MRI can also reveal a tumor's interior landscape, or it's heterogeneity. Knopp says some tumors are extremely heterogeneous - meaning they are not biologically uniform. Instead, many may contain clusters of "hot spots," clumps of cells that are biologically different and often resistant to treatment. "Functional MRI can help us identify those areas, understand their particular features, and hopefully, design targeted therapies for those specific sites," says Knopp.

In functional MRI, images are made by measuring minute radio waves produced when hydrogen atoms in the body are trapped and vibrate within a magnetic field. The varying intensity of the signal reveals structural features and biological patterns illuminated by injected contrast agents.

"Analyzing data from those images can help us literally see where some chemotherapies are effective, and others are not. We know, for example, that in many cases, treatment with chemotherapy may kill 70 or 80 percent of a cancer, but the remaining tumor cells remain problematic. Now, we can find out exactly where those resistant areas are and we can be more selective and precise with additional treatment," says Knopp. (See http://www.jamesline.com/output/breastimages.htm for an illustration.)

While functional MRI offers new ways to visualize cancer at work, it presents several problems that need to be solved before it becomes routinely useful in clinical care. It is still so new that scientists have yet to agree on standard methodology they will use to visualize what they want to see. That makes comparing studies and findings across multiple centers difficult. In addition, one study alone can generate as many as 700-800 images that need to be synthesized and read collectively for a complete analysis - a process requiring substantial computational power and highly-trained specialists.

"It's an emerging field, and we think we are just beginning to see what it can do," says Knopp.

Knopp reviewed functional MRI in oncology in an article in the April issue of Molecular Cancer Therapeutics.
-end-
His research is supported by the National Cancer Institute,The Wright Center of Innovation and the Ohio Biomedical Research and Technology Transfer Fund.

Ohio State University Wexner Medical Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.